rs11103563
Variant names:
Variant summary
Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1
The NM_004108.3(FCN2):c.694+288A>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.135 in 152,142 control chromosomes in the GnomAD database, including 1,465 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Genomes: 𝑓 0.14 ( 1465 hom., cov: 32)
Consequence
FCN2
NM_004108.3 intron
NM_004108.3 intron
Scores
2
Clinical Significance
Not reported in ClinVar
Conservation
PhyloP100: -1.47
Publications
8 publications found
Genes affected
FCN2 (HGNC:3624): (ficolin 2) The product of this gene belongs to the ficolin family of proteins. This family is characterized by the presence of a leader peptide, a short N-terminal segment, followed by a collagen-like region, and a C-terminal fibrinogen-like domain. This gene is predominantly expressed in the liver, and has been shown to have carbohydrate binding and opsonic activities. Alternatively spliced transcript variants encoding different isoforms have been identified. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.95).
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.192 is higher than 0.05.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| FCN2 | NM_004108.3 | c.694+288A>G | intron_variant | Intron 7 of 7 | ENST00000291744.11 | NP_004099.2 | ||
| FCN2 | NM_015837.3 | c.580+288A>G | intron_variant | Intron 6 of 6 | NP_056652.1 | |||
| FCN2 | XM_011518392.4 | c.661+288A>G | intron_variant | Intron 7 of 7 | XP_011516694.1 | |||
| FCN2 | XM_006717015.5 | c.547+288A>G | intron_variant | Intron 6 of 6 | XP_006717078.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.135 AC: 20568AN: 152024Hom.: 1465 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
20568
AN:
152024
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome AF: 0.135 AC: 20592AN: 152142Hom.: 1465 Cov.: 32 AF XY: 0.134 AC XY: 9930AN XY: 74376 show subpopulations
GnomAD4 genome
AF:
AC:
20592
AN:
152142
Hom.:
Cov.:
32
AF XY:
AC XY:
9930
AN XY:
74376
show subpopulations
African (AFR)
AF:
AC:
8126
AN:
41488
American (AMR)
AF:
AC:
1915
AN:
15292
Ashkenazi Jewish (ASJ)
AF:
AC:
145
AN:
3464
East Asian (EAS)
AF:
AC:
935
AN:
5166
South Asian (SAS)
AF:
AC:
586
AN:
4822
European-Finnish (FIN)
AF:
AC:
1001
AN:
10600
Middle Eastern (MID)
AF:
AC:
11
AN:
294
European-Non Finnish (NFE)
AF:
AC:
7574
AN:
67992
Other (OTH)
AF:
AC:
280
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
899
1798
2696
3595
4494
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
226
452
678
904
1130
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
539
AN:
3478
ClinVar
Not reported inComputational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.